Hiva Kolodrubetz, NP, provides an engaging and detailed session on anti-diabetic medications, focusing on safe prescribing and effective management strategies. Highlighting pharmacological mechanisms, A1C goals, and patient-centered care,…
Associate Professor Mike Todorovic, AKA “Dr. Mike”, introduces the endocrine system, explaining how hormones act as chemical messengers released into the bloodstream by cells, tissues, and glands. He…
NEW YORK (Reuters Health) – Taking levothyroxine on an empty stomach at bedtime, instead of in the morning before breakfast, significantly improves thyroid hormone levels and many patients…
NEW YORK (Reuters Health) – A new test makes feasible the early detection of Turner syndrome, according to a report in the December 8 issue of The Journal…
NEW YORK (Reuters Health) – A study of Chernobyl survivors shows no difference in recurrence patterns between radiation-related and sporadic thyroid cancers. “Similar treatment approaches should be recommended…
NEW YORK (Reuters Health) – For women of normal weight or moderate overweight who develop gestational diabetes late in pregnancy, treatment with metformin may be a suitable alternative…
NEW YORK (Reuters Health) – The management of heart failure guided by an individualized target level of N-terminal pro-B-type natriuretic peptide (NT-proBNP) doesn’t lead to clinically significant improvements…
NEW YORK (Reuters Health) – The mineralocorticoid receptor blocker eplerenone has advantages over spironolactone in the treatment of chronic heart failure (CHF), a Japanese team reports. In particular,…
NEW YORK (Reuters Health) – Elevated systolic blood pressure and low diastolic blood pressure are associated with increased risk of cardiovascular disease (CVD) among patients with type 2…
NEW YORK (Reuters Health) – Short-term testosterone treatment in frail elderly men improves muscle mass and strength, but the effects don’t last more than 6 months after treatment…
NEW YORK (Reuters Health) – A population-based study from Scotland shows that fewer than one in every 100 patients with subclinical hyperthyroidism will progress to overt hyperthyroidism. In…
